Oculoplastic Surgery — Specialty Profile

Exploratory, not prescriptive. This profile blends hard data (pay, match rates, burnout, demographics, each sourced and dated) with generalizations and synthesized opinion about culture and "who fits." It's here to help you get curious and go find out for yourself, not to tell you who to become. Numbers marked ⟳ verify change every year; check the linked source before you quote one. Last reviewed: 2026-08-04.

Also called: oculoplastics, oculofacial plastic surgery, ophthalmic plastic and reconstructive surgery, ASOPRS fellowship. A 2-year fellowship entered after an ophthalmology residency, not a residency you match into from medical school. Organ systems: the eyelids, orbit, tear drainage system, and the face around the eye.

Subspecialty fellowship of Ophthalmology.

The 30-second version

Oculoplastic surgery is the part of ophthalmology that operates on everything around the eye rather than on the eye itself, and it is the only ophthalmology subspecialty with a genuine cosmetic practice attached. The territory is eyelids, orbit, and the lacrimal drainage system: ptosis repair in a patient whose lid is blocking their vision, orbital decompression in thyroid eye disease, orbital fracture repair, tumor resection and reconstruction, tear duct surgery, and the management of an eye socket after an eye is removed. Alongside all of that sits blepharoplasty, brow lift, and periocular injectables, which are cash-pay and which give this subspecialty an income structure the rest of ophthalmology does not have. The credentialing is unusual even by ophthalmology's standards: there is no ABMS subspecialty board, and instead the field runs on a society credential that requires a two-year fellowship, a written examination, an oral examination, and an approved thesis. The trade at the center of the field: the most competitive fellowship in ophthalmology and the one with the highest earning ceiling, reached through a gate that closes earlier in residency than any other.

Quick dashboard (details and sources below)


Training after med school	6 years (1 intern year + 3 yr ophthalmology + 2 yr ASOPRS fellowship)
Total from college start	~14 years (4 undergrad + 4 med school + 4 ophthalmology training + 2 fellowship)
Training chain	Med school (4) → intern year → Ophthalmology (3 yr, SF Match) → 2 yr ASOPRS fellowship (SF Match)
Competitiveness (as an ophthalmology fellowship)	The hardest in the field. About 20–25 positions per cycle against roughly 60–100 applicants ⟳
Typical full-time pay	No oculoplastics survey line. Parent ophthalmology runs ~$410,000–$490,000, with partners and owners around $610,000, and this subspecialty sits at the upper end ⟳
Pay vs. parent (comprehensive ophthalmology)	Above, driven by a cash-pay cosmetic component the rest of the field lacks ⟳
Lifestyle	Outpatient, elective, light call, with orbital trauma as the exception ⟳
Burnout	No subspecialty figure; parent ophthalmology is 25.8% against a 41.9% all-physician average (AMA 2025), second-lowest of the rows it names ⟳
% women	No published subspecialty figure; parent ophthalmology 28% practicing and 42.6% of residents ⟳
DO / IMG accessibility	Gated behind one of the least open residencies (DO seniors ~34% match rate; IMG ~2% of matched) ⟳

What they actually do

Eyelid surgery is the volume. Ptosis repair, where a drooping upper lid obstructs the visual field, is the bread and butter, alongside ectropion and entropion correction, eyelid reconstruction after skin cancer excision, and functional blepharoplasty for dermatochalasis heavy enough to affect vision. A large share of the reconstructive work arrives from Mohs surgery, because periocular basal cell carcinoma is common and the defect it leaves needs an eyelid rebuilt around a functioning tear film.

Orbital surgery is the demanding end. Orbital decompression for thyroid eye disease, orbital fracture repair, drainage of orbital cellulitis and abscess, biopsy and resection of orbital tumors including lymphoma and lacrimal gland lesions, and enucleation, evisceration, and exenteration with the socket reconstruction that follows. Orbital surgery works in a confined space against the optic nerve, and the margin for error is small.

The lacrimal system is its own domain: dacryocystorhinostomy, both external and endoscopic, for tear duct obstruction, and probing and intubation in children with congenital obstruction.

Cosmetic periocular surgery is the economically distinctive half. Cosmetic blepharoplasty, brow and midface lifting, and periocular neuromodulator and filler injection. This is a cash-pay practice, and it is the reason oculoplastic surgeons occupy a different economic position from the rest of ophthalmology. The overlap here is with facial plastic surgery, and the two fields compete for the same periocular cosmetic patients from different training routes.

Representative procedures: ptosis repair (levator advancement, Müller's muscle conjunctival resection, frontalis sling) · functional and cosmetic blepharoplasty · ectropion and entropion repair · eyelid reconstruction after Mohs excision · orbital decompression · orbital fracture repair · orbital tumor biopsy and excision · enucleation, evisceration, and exenteration with socket reconstruction · dacryocystorhinostomy · brow and midface lifting · periocular neuromodulator and filler injection · management of thyroid eye disease, including the newer biologic therapies.¹²

A day in the life: clinic and operating room in an outpatient rhythm. Most cases are short, elective, and done under local anesthesia with sedation, so the operative day is a list rather than a marathon. Clinic mixes functional consultations, post-operative follow-up, thyroid eye disease management shared with endocrinology, and cosmetic consultations that run differently from medical ones because they are a sales conversation as well as a clinical one. Photography and visual field testing for functional documentation are routine, since insurers require proof that a ptosis repair is functional rather than cosmetic.

On call: light but real. Orbital trauma, retrobulbar hemorrhage, and orbital cellulitis arrive through the emergency department, and a retrobulbar hemorrhage threatening the optic nerve is a genuine sight-threatening emergency requiring immediate canthotomy and cantholysis.

The training path & time to completion

Medical school (4 yrs) → PGY-1 intern year → ophthalmology residency (3 yrs, PGY-2 to PGY-4, entered through the separate SF Match) → 2-year ASOPRS fellowship → practice.¹³

The residency is one of the hardest gates in medicine, matched through the separate and earlier SF Match, with DO seniors matching at roughly 34% and IMGs at about 2% of matched positions.⁴ The parent ophthalmology profile covers it.
The fellowship is two years, which along with vitreoretinal surgery makes it one of the two longest in ophthalmology, where most others run one.²³
It matches through SF Match under ASOPRS sponsorship. For the 2027–2029 positions, registration opened December 1, 2025, applications closed February 4, 2026, rank lists were due June 8, 2026, and results were released June 15, 2026.¹
Applications go in earlier than any other ophthalmology fellowship. Applicants submit by early in the fall of their second year of residency, meaning PGY-3, which is roughly a year ahead of the rest of the field. Anyone who discovers oculoplastics late in residency has effectively missed the cycle.⁵
Eligibility is completion of an ACGME-approved ophthalmology residency and eligibility for licensure in the fellowship's state or province.¹
Total from the start of college: about 14 years, two more than comprehensive ophthalmology's 12.

The credential is a society membership, not a board

This is the structural fact that most surprises people coming from other specialties. The American Board of Ophthalmology issues no subspecialty certificates at all, so an oculoplastic surgeon remains board-certified in general ophthalmology, exactly as a retina surgeon does.⁴

What stands in its place is ASOPRS membership, and it is a substantial credential rather than a formality. After the two-year fellowship, a candidate must pass a written examination and an oral examination and complete an approved thesis to become a member.¹ A thesis requirement is unusual in American subspecialty training, and it means the credential takes years beyond fellowship to complete. In practice, ASOPRS membership is what the field and its referring physicians treat as the marker of a fellowship-trained oculoplastic surgeon.

How competitive is it?

This is the most competitive fellowship in ophthalmology, and unlike much of the field, there are numbers.

About 20 to 25 ASOPRS fellowship positions are available in a given cycle, against approximately 60 to 100 applicants.⁵ ⟳
Most sites train one fellow at a time. ASOPRS fellowships are two years and run on an "even year" or "odd year" cycle, with the fellow finishing both years before the next one starts, so a program is generally recruiting in one cycle out of two. A handful of sites run an even-year and an odd-year fellow simultaneously. That structure, rather than a small number of institutions, is why the per-cycle position count is as low as it is.¹⁵ ⟳
The effective number of open positions is smaller than the advertised one. Some positions fill internally with a program's own residents, and some programs choose not to take a fellow in a given cycle, which compresses an already small pool.⁵ ⟳
The upstream residency is itself one of the hardest matches in medicine, comparable to dermatology and plastic surgery.⁴ Everyone applying has already cleared it.
The early timeline is a filter in its own right. Applying in the fall of PGY-3 means committing to the subspecialty roughly eighteen months into a three-year residency, before most residents have completed their subspecialty rotations.⁵

The honest read. Two selective gates in sequence, and the second is genuinely competitive on the numbers rather than only in reputation. Roughly one applicant in three to four gets a position. What determines the outcome is early commitment, research in oculoplastics, and mentorship inside a department that has an ASOPRS program, which is a connection-sensitive selection much like the one the Mohs surgery profile describes on the dermatology side.

Board: none specific to the subspecialty. Certification is general ophthalmology through the American Board of Ophthalmology; the field's credential is ASOPRS membership, requiring written and oral examinations and an approved thesis.¹⁴

Compensation — the robust version

No compensation survey isolates oculoplastic surgery. What can be said rests on the parent field's structure and on one clear mechanism.

The parent anchor. Comprehensive ophthalmology runs roughly $410,000–$490,000 total compensation, with a W-2 employee figure near $476,000, partners and owners near $610,000, and retina, the field's high earner, near $700,000.⁴ ⟳

Oculoplastics sits at the upper end of that range, and the reason is specific. It is the only ophthalmology subspecialty with a substantial cash-pay cosmetic practice. Cosmetic blepharoplasty, brow lifting, and periocular injectables are paid directly by patients at prices the surgeon sets, without insurer negotiation, denial, or reimbursement cuts. That is a fundamentally different revenue model from the rest of ophthalmology, which runs on Medicare-heavy surgical and clinic billing.

The structure of an oculoplastics income is therefore two-sided:

The functional and reconstructive half is insurance-billed and behaves like the rest of ophthalmology: ptosis repair, orbital surgery, lacrimal surgery, and Mohs reconstruction, with the documentation burden that comes with proving a procedure is functional.
The cosmetic half is cash-pay, higher-margin, and scalable with reputation and marketing, and it is where the ceiling comes from. A surgeon with an established aesthetic practice occupies a different economic position from one doing only reconstructive work.

The same dynamic appears in the facial plastic surgery profile, which documents the cosmetic cash-pay tail as the reason that subspecialty out-earns its own parent field. Oculoplastics is the ophthalmology version of the same structure.

The honest counterweight. Academic oculoplastic surgeons doing mostly orbital and reconstructive work do not have that tail and are paid academic rates. The subspecialty does not guarantee the ceiling; the practice model does. And a cosmetic practice takes years to build and depends on a market that can pay cash, which is geographically uneven.

Limited-data caveat: no MGMA, Doximity, or Medscape line for oculoplastic surgery was located. The parent figures are sourced; the position within the range is a structural inference from the cash-pay component. Benchmark against comprehensive ophthalmology and against the specific reconstructive-to-cosmetic ratio of the job. ⟳

Lifestyle

Parent ophthalmology has one of the best lifestyle profiles in medicine: outpatient, elective surgery, light call, and among the lowest burnout of any specialty the AMA's 2025 survey names.⁴ Oculoplastics keeps almost all of it.
The operative day is short-case and outpatient. Most procedures run under local anesthesia with sedation in an ambulatory setting, so operative days are lists rather than marathons.
Call is light but genuinely sight-threatening when it comes. Retrobulbar hemorrhage, orbital cellulitis, and orbital trauma arrive unscheduled, and a retrobulbar hemorrhage needs decompression within minutes to save the optic nerve.
The cosmetic practice changes the week's texture. Aesthetic patients expect availability, follow-up, and a level of service medical practice does not, and marketing and reputation management become part of the job.
Geographic flexibility is good for the reconstructive practice and uneven for the cosmetic one. Eyelid and orbital disease exists everywhere; a cash-pay aesthetic practice needs a market with disposable income.

Lifestyle rating: 4/5. Outpatient, elective, and controllable, deducted for genuine sight-threatening emergencies and for the service demands of an aesthetic practice.

Wellbeing — the part to take seriously

No oculoplastics-specific wellbeing data exists. Inherit ophthalmology, which sits at 25.8% burnout against a 41.9% all-physician average, second-lowest of the rows the AMA's 2025 Organizational Biopsy names.⁴ ⟳

The distinctive satisfaction is visible restoration. A ptosis repair opens a visual field a patient had lost; an eyelid reconstruction after cancer excision rebuilds a face; an orbital decompression relieves a proptosis that had changed how someone looked to themselves. This field changes both function and appearance, and patients respond to that combination strongly.

The distinctive stress has two parts. The first is anatomical: the orbit is a confined space with the optic nerve running through it, and orbital surgery carries a small but real risk of blindness. The second is aesthetic expectation. Cosmetic eyelid surgery is judged by the patient against an idea in their head, and a technically excellent blepharoplasty can leave a patient unhappy in a way a technically excellent cataract extraction cannot. Managing that gap, and declining to operate on patients whose expectations cannot be met, is a real professional skill and a real source of strain.

The thesis and examination tail deserves mention. Completing ASOPRS membership requires a written exam, an oral exam, and an approved thesis after a two-year fellowship, which extends the professional formation of this field well past the point where most subspecialists are simply practicing.¹

Career longevity is good. The ergonomics are outpatient and seated, the call burden is light, and an aesthetic practice can be tapered by choice rather than by physical necessity.

Who's in the field (demographics)

No published oculoplastics-specific demographic data was located. Inherit ophthalmology, directionally.

Women: no subspecialty figure. Parent ophthalmology runs 28% women practicing on AAMC's 2022 data and 42.6% of residents in AY2024-25, so the pipeline is well ahead of the practicing workforce.⁴ ⟳ ACGME's four accredited programs in this subspecialty held five fellows in AY2024-25, all five of them women, which is too small a count to read as a rate.
DO: low and set upstream. DO seniors match ophthalmology at roughly 34%, and the residency is among the least open in medicine.⁴ ⟳
IMG: very low, at roughly 2% of matched ophthalmology positions.⁴ ⟳
Underrepresented in medicine: no subspecialty figure. Ophthalmology has been among the less diverse specialties, and a fellowship this small and this connection-sensitive would not be expected to improve on its parent. ⟳
A structural note. Because applications close in the fall of PGY-3, the applicants who succeed are disproportionately those who arrived at residency already knowing about the subspecialty, which favors people with prior exposure and mentorship. That is a quiet access filter. ⟳

Culture, personality & the online stereotypes

Who gravitates here: ophthalmology residents who wanted to operate more, and to operate on something other than the globe. The field draws people with an interest in reconstruction and in facial aesthetics, and it rewards fine technical work in a small anatomical space. It also selects for people comfortable with the commercial side of medicine, since running a cosmetic practice involves pricing, marketing, and consultation skills that medical training does not teach. As always, plenty of people in the field do not fit any single mold.

The stereotypes. Community perception rather than fact, each with a kernel and an unfair edge:

"The eye surgeons who do not touch the eye." Literally accurate and meant as a jab. Oculoplastics operates on the adnexa rather than the globe, which is exactly why it is a distinct subspecialty.
"Ophthalmology's plastic surgeons." Broadly fair, and the reason for both the earning ceiling and a degree of ambivalence inside a specialty whose self-image is medical.
"The hardest fellowship to get and the earliest to apply for." Supported by the numbers, at roughly 20 to 25 positions for 60 to 100 applicants, with applications due a full year ahead of the rest of the field.⁵
"A thesis? In 2026?" The recurring complaint about ASOPRS membership requirements, which include a written exam, an oral exam, and an approved thesis. Members generally defend it as what keeps the credential meaningful in the absence of an ABMS board.

What people say online (synthesized and paraphrased, not quotes): across trainee and physician forums resources, oculoplastics reads as the field's most competitive and most commercially interesting subspecialty. The single most repeated piece of practical advice concerns timing: you must decide early, because the application closes in the fall of PGY-3, and residents who realize in their third year that they want it have generally missed it. A second recurring theme is the internal-match dynamic, with posters noting that programs frequently fill with their own residents, which compresses the externally available positions further. A third is the cosmetic question, discussed openly, with the consensus being that the aesthetic practice is where the income difference lives and that building one is a business skill rather than a clinical one. A fourth is the thesis, discussed with a mixture of grumbling and pride. The tone is competitive and business-aware.

Voices from the field. Paraphrased from published sources, with links to the originals:

ASOPRS describes its fellowships as highly competitive two-year full-time positions at academic institutions in the United States and Canada, matched through SF Match, requiring completion of an ACGME-approved ophthalmology residency, with membership contingent on written and oral examinations and an approved thesis.¹
Practical guidance for applicants documents about 20 to 25 positions per cycle against approximately 60 to 100 applicants, with some positions filling internally and some programs declining to take a fellow, and an application deadline in the early fall of PGY-3, earlier than any other ophthalmology subspecialty.⁵
Most of ophthalmology's fellowship structure is non-ACGME, overseen by the AUPO Fellowship Compliance Committee and matched through SF Match, and the American Board of Ophthalmology issues no subspecialty certificates. This subspecialty is the exception on accreditation, and it is a small one: ACGME accredits four ophthalmic plastic and reconstructive surgery programs, holding five fellows in AY2024-25, alongside the much larger ASOPRS route that runs outside accreditation.²⁴

Why people choose it / why people leave

Why choose it: the highest earning ceiling in ophthalmology, driven by a cash-pay cosmetic practice the rest of the field does not have · reconstructive surgery with visible, function-restoring results · orbital surgery, which is technically demanding work in a confined and consequential space · an outpatient, elective, light-call life inherited from one of medicine's best-lifestyle specialties · a genuinely distinct anatomical territory · a credential the field takes seriously.

Why leave or avoid it: the most competitive fellowship in ophthalmology, at roughly 20 to 25 positions for 60 to 100 applicants · an application deadline in the fall of PGY-3, which requires deciding before most residents know · two years of fellowship on top of an already-long path · a thesis, a written exam, and an oral exam after fellowship for ASOPRS membership · aesthetic patient expectations, which are a different professional burden from clinical risk · sight-threatening emergencies in orbital hemorrhage and cellulitis · no ABMS subspecialty board.

Best fit if: you want to operate more than comprehensive ophthalmology allows · reconstruction and facial aesthetics both interest you · you are comfortable with the commercial side of a cosmetic practice · you knew early in residency that this was what you wanted · you want ophthalmology's income ceiling.

Not for you if: you discovered the subspecialty in PGY-4, in which case the timeline has probably already closed · cosmetic medicine does not appeal to you · you want a shorter path to attending life · you would resent a thesis requirement · you want an ABMS subspecialty certificate.

The FLI angle — Oculoplastic surgery for first-gen, low-income & immigrant students

Where it fits FLI realities well:

The income ceiling is the highest in ophthalmology, and ophthalmology is already a well-paid specialty. Between the parent field's $410,000–$490,000 base, partner and owner figures near $610,000, and a cash-pay cosmetic layer on top, this is a genuinely family-trajectory-changing income.⁴
The lifestyle is sustainable, outpatient and light-call, and the parent field records among the lowest burnout on the AMA's 2025 table, at 25.8% against a 41.9% all-physician average.⁴
The reconstructive practice travels well. Eyelid and orbital disease exists in every market, so the functional half of the practice does not require a wealthy metropolitan area even though the cosmetic half does.

Risks to name honestly, and there are several serious ones:

The residency is among the least FLI-accessible gates in medicine. DO seniors match ophthalmology at roughly 34% and IMGs make up about 2% of matched positions, and the match runs early and separately through SF Match, which changes how a backup plan works.⁴ Reaching this subspecialty means clearing that first, and the research and away-rotation costs are real.
The PGY-3 application deadline is a structural disadvantage for anyone without early mentorship, and this is the most important thing on this page. You have to know this subspecialty exists, want it, and have research and a relationship with an oculoplastics faculty member roughly eighteen months into residency.⁵ Students who arrive at residency with family in medicine or with an undergraduate research network are systematically better positioned to do that. If oculoplastics interests you at all, the practical instruction is to find the ASOPRS-affiliated surgeon at your institution in your first months of residency, not your second year.
Internal filling compresses the odds further. A meaningful share of positions go to a program's own residents, so being at an institution with an ASOPRS fellowship is a substantial advantage you may not be able to choose.⁵
PSLF fits this path poorly. The high-earning version of this career is private practice with a cosmetic component, and private practices generally do not qualify. Academic oculoplastics qualifies and pays considerably less. As elsewhere on this site, the two levers point in opposite directions and the choice should be deliberate.
The cosmetic practice requires capital, patience, and a market. Building an aesthetic practice takes years and often marketing investment, so plan for the reconstructive income in your early years and treat the ceiling as a later-career outcome.

Bottom line for FLI: the highest ceiling in a top-lifestyle specialty, behind two of the least accessible gates in medicine and one deadline that closes earlier than almost anyone expects. If this field interests you, the single highest-leverage action is early: identify an oculoplastic surgeon in your first months of ophthalmology residency and start the research relationship then. Everything else about this path is downstream of that timing, and the timing is the part that quietly selects for people who already knew.

Fun facts

The American Board of Ophthalmology issues no subspecialty certificates at all, so an oculoplastic surgeon and a retina surgeon are both, formally, board-certified general ophthalmologists.⁴
The credential is a thesis. ASOPRS membership requires a written examination, an oral examination, and an approved thesis after the two-year fellowship, which is unusual in American subspecialty training.¹
You apply a year before everyone else. Oculoplastics applications close in the early fall of PGY-3, roughly a year ahead of the other ophthalmology fellowships.⁵
It is the only ophthalmology subspecialty with a real cash-pay cosmetic practice, which is why its income structure looks more like facial plastic surgery than like the rest of ophthalmology.
Retrobulbar hemorrhage is one of medicine's shortest clocks. Pressure behind the eye can take the optic nerve within minutes, and the treatment is a bedside canthotomy and cantholysis.
A large share of the reconstructive work comes from dermatology. Periocular skin cancers excised by Mohs surgeons arrive here for the eyelid to be rebuilt.

Sources

Fellowship structure, match, eligibility, and credential. American Society of Ophthalmic Plastic and Reconstructive Surgery — ASOPRS Fellowships: highly competitive two-year full-time fellowship positions affiliated with academic institutions in the US and Canada; all applicants participate in SF Match, with the 2026 cycle for 2027–2029 positions opening registration December 1, 2025, applications completed by February 4, 2026, rank lists due June 8, 2026, results June 15, 2026, and post-match vacancies announced June 16, 2026; applicants must have completed an ACGME-approved ophthalmology residency and be eligible for licensure in the state or province of the fellowship; ASOPRS membership requires passing written and oral examinations and completing an approved thesis. https://www.asoprs.org/asoprs-fellowships (accessed 2026). ↩ ↩² ↩³ ↩⁴ ↩⁵ ↩⁶ ↩⁷ ↩⁸ ↩⁹ ↩¹⁰
Ophthalmology's fellowship structure, and where this subspecialty sits outside it. Most ophthalmology fellowships are overseen by the AUPO Fellowship Compliance Committee and matched through the SF Match Central Application Service rather than through ACGME and the NRMP; most run one year, with vitreoretinal surgery and oculoplastics the two-year exceptions. Association of University Professors of Ophthalmology, SF Match (https://aupo.org/sfmatch), accessed 2026. The vitreoretinal surgery profile on this site documents the same structure for retina. Ophthalmic plastic and reconstructive surgery is the accreditation exception, and this is the page it belongs on: ACGME's Data Resource Book, Academic Year 2024-2025 carries a row for it under Ophthalmology — 4 accredited programs and 5 fellows, all five women, against 128 ophthalmology residency programs and 1,790 residents — and the book counts accredited programs. https://www.acgme.org/globalassets/pfassets/publicationsbooks/2024-2025_acgme_databook_document.pdf Swept 2026-08-17: this page said ophthalmology's fellowship structure "is non-ACGME throughout," a claim about the whole class that its own subspecialty refutes, and it said it in the section about this subspecialty's training. The two routes coexist: four accredited programs, and the larger ASOPRS two-year fellowship at [^1], which runs outside accreditation and is what most oculoplastic surgeons complete. Neither statement replaces the other. The same class-wide claim was scoped on the glaucoma, cornea and external disease and vitreoretinal surgery profiles. ⟳ ↩ ↩² ↩³
Clinical scope and fellowship content — eyelid, orbit, and lacrimal surgery plus periocular aesthetics. Composite of published US oculofacial plastic surgery fellowship curricula: Johns Hopkins Wilmer Oculoplastics Fellowship (https://www.hopkinsmedicine.org/wilmer/education/clinical-training/fellowships/oculoplastics), OHSU Casey Eye Institute Oculofacial Plastic, Orbital and Reconstructive Surgery Fellowship (https://www.ohsu.edu/casey-eye-institute/oculofacial-plastic-orbital-and-reconstructive-surgery-fellowship), and Duke Eye Center Oculofacial and Orbital Surgery Fellowship (https://dukeeyecenter.duke.edu/education-and-training/fellowship-programs/oculofacial-and-orbital-surgery-fellowship), accessed 2026. ↩ ↩²
Parent-field figures for ophthalmology. Compensation, training length, competitiveness, and the absence of any American Board of Ophthalmology subspecialty certificate: typical comp ~$410k–$490k, with W-2 employee ~$476k, partner or owner ~$610k, and retina ~$700k; 4 years of training (1 intern + 3 ophthalmology) and ~12 years from the start of college; competitiveness rivaling dermatology and plastics, matched through the separate SF Match. Those are carried from the ophthalmology and vitreoretinal surgery profiles on this site, which are cross-references rather than sources; the surveys and the ABO's own statement sit on those pages. Burnout: AMA Organizational Biopsy 2025 — nearly 19,000 physician responses across 106 health systems in 38 states — puts Ophthalmology at 25.8% against a 41.9% all-physician average, second-lowest of the rows it names, https://www.ama-assn.org/practice-management/physician-health/these-9-physician-specialties-report-highest-burnout-rates. Corrected 2026-08-17: the dashboard and the wellbeing section now lead with the AMA row rather than Medscape's 39%. AMA is the instrument this page prefers wherever it publishes a row, because it is free, primary and current, and ophthalmology is one of the roughly fifteen the Organizational Biopsy breaks out. A Medscape-frame rank is not restated in the AMA frame; the two baselines are seven points apart. The Medscape reading, no longer the page's anchor: 39% against a 49% all-physician average — Physician Burnout & Depression Report 2024 (n=9,226, fielded July–October 2023), paywalled and returning HTTP 402. Corrected 2026-08-17: this footnote claimed three independent relays agreeing on every row and then named two. Only Healthgrades Pro (https://resources.healthgrades.com/pro/the-most-and-least-burned-out-physicians-by-specialty) prints an ophthalmology row; Advisory Board (https://www.advisory.com/daily-briefing/2024/01/31/physician-burnout) carries no specialty table and does not corroborate it. Women practicing, 28%: AAMC, "Women are changing the face of medicine in America" (2022 data), https://www.aamc.org/news/women-are-changing-face-medicine-america, which puts ophthalmology at 28% against a 38% all-physician share for the same year; the all-physician figure is 38.7% on 2024 data, AAMC 2025 Key Findings, https://www.aamc.org/data-reports/data/2025-key-findings. Residents, 42.6%: ACGME, Data Resource Book, Academic Year 2024-2025, Table C.21, https://www.acgme.org/globalassets/pfassets/publicationsbooks/2024-2025_acgme_databook_document.pdf . Swept 2026-08-17: this footnote said in bold that the body's own number disagreed with the primary, and the body went on printing "~25–26%" in the dashboard and the demographics bullet. Both now say 28% and the resident band is given exactly. The disagreement note is gone because there is no longer a disagreement. The same table gives this subspecialty 5 fellows in 4 accredited programs, all five women. The DO and IMG figures have no NRMP source and cannot have one, because ophthalmology matches through SF Match rather than the NRMP; the ~34% DO senior match rate and ~2% IMG share of matched positions are carried from the ophthalmology profile on this site and rest on SF Match reporting, and they should be read as that rather than as Match-report data. ⟳ ↩ ↩² ↩³ ↩⁴ ↩⁵ ↩⁶ ↩⁷ ↩⁸ ↩⁹ ↩¹⁰ ↩¹¹ ↩¹² ↩¹³ ↩¹⁴ ↩¹⁵
Competitiveness and application timing. Applicant guidance, verbatim: "Depending on the cycle, there are typically between 20-25 ASOPRS fellowship slots available. In reality, that number shrinks because some of them will de facto fill internally and some of them will opt not to accept a fellow for that cycle. Each year, there are approximately 60-100 applicants." The same page describes the even-year and odd-year structure: "Most ASOPRS fellowship sites only have one fellow at a time, with the fellow completing the entire 2 years of training before the next fellow comes on board," with a few sites running one of each. Corrected 2026-08-17: this page also carried "roughly 15 to 17 approved programs" per cycle, in the dashboard, the competitiveness section and Voices from the field. Neither cited source states a program count — OphthoQuestions gives positions and applicants only, and ASOPRS gives the even/odd structure — and 15 to 17 does not reconcile with one fellow per site against 20 to 25 positions. The count is dropped rather than estimated. Applications must be submitted by the early fall of the second year of ophthalmology residency (PGY-3), earlier than any other ophthalmology subspecialty. OphthoQuestions, "Tips and Considerations for Applying to Oculoplastics." https://www.ophthoquestions.com/posts/tips-and-considerations-for-applying-to-oculoplastics (accessed 2026). ⟳ ↩ ↩² ↩³ ↩⁴ ↩⁵ ↩⁶ ↩⁷ ↩⁸ ↩⁹ ↩¹⁰

Researched with AI assistance and reviewed by hand. How this site is made